Gonadotropin-releasing hormone agonist-induced hypoestrogenism and blood flows in cerebral arteries. 1996

M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
Istituti Clinici di Perfezionamento, University of Milan, Italy.

OBJECTIVE To evaluate the effect of the hypoestrogenism induced by GnRH agonist (GNRH-a) therapy on cerebral vessel blood flow. METHODS Open, controlled study. METHODS Tertiary care units of the University of Milan, Italy. METHODS Young women scheduled to undergo 6 months of therapy with a GnRH-a; a control group was also enrolled. METHODS In both groups, the pulsatility index of both the internal carotid artery (ICA) and middle cerebral artery (MCA) was measured by means of Doppler ultrasound over a period of 6 months. METHODS The ICA and MCA pulsatility index. RESULTS No variation in the pulsatility index of either artery was found in either group. CONCLUSIONS A 6-month period of GnRH-a-induced hypoestrogenism in young women does not lead to any variation in the blood flow of cerebral vessels. This provides some reassurance as to the safety of these drugs in relation to the role that the reactivity of peripheral arteries may play in determining risk of cardiovascular disease. Furthermore, our results show that blood flow in the cerebral vessels of young subjects is under extraestrogenic control and that this may counterbalance estrogen deprivation through mechanisms that probably are no longer active in the perimenopausal years.

UI MeSH Term Description Entries
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D002343 Carotid Artery, Internal Branch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose. Arteries, Internal Carotid,Artery, Internal Carotid,Carotid Arteries, Internal,Internal Carotid Arteries,Internal Carotid Artery
D002536 Cerebral Arteries The arterial blood vessels supplying the CEREBRUM. Arteries, Cerebral,Artery, Cerebral,Cerebral Artery
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017329 Triptorelin Pamoate A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6. D-Trp-6-LH-RH,LHRH, Trp(6)-,Triptorelin,6-D-Tryptophan-Luteinizing Hormone-Releasing Factor (Pig),AY-25650,CL-118532,Decapeptyl,Decapeptyl Depot,Decapeptyl LP,Decapeptyl Trimestral,GnRH, Trp(6)-,LHRH, Tryptophyl(6)-,Trelstar,Triptorelin Embonate,Wy-42462,AY 25650,AY25650,CL 118532,CL118532,Embonate, Triptorelin,Pamoate, Triptorelin,Trimestral, Decapeptyl,Wy 42462,Wy42462

Related Publications

M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
January 2016, Endocrinology, diabetes & metabolism case reports,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
September 2009, American journal of physiology. Cell physiology,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
October 1984, Fertility and sterility,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
November 1990, American journal of obstetrics and gynecology,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
June 1994, American journal of obstetrics and gynecology,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
December 2013, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
January 2016, Endocrine development,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
April 1992, New Jersey medicine : the journal of the Medical Society of New Jersey,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
January 1994, Acta Europaea fertilitatis,
M Penotti, and M Farina, and L Gabrielli, and L Miglierina, and A M Miragoli, and M Vignali
September 1988, Journal of animal science,
Copied contents to your clipboard!